Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 611

Similar articles for PubMed (Select 18042482)

1.

Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes.

Orzeck EA, Shi N, Blumentals WA.

Clin Ther. 2007 Oct;29(10):2246-55.

PMID:
18042482
3.

Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children.

Gums JG, Pelletier EM, Blumentals WA.

Expert Opin Pharmacother. 2008 Feb;9(2):151-61. doi: 10.1517/14656566.9.2.151 .

PMID:
18201141
4.

Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005.

Peters PH, Moscona A, Schulman KL, Barr CE.

Medscape J Med. 2008 Jun 4;10(6):131.

5.

Effects of oseltamivir on influenza-related complications in children with chronic medical conditions.

Piedra PA, Schulman KL, Blumentals WA.

Pediatrics. 2009 Jul;124(1):170-8. doi: 10.1542/peds.2008-0977.

PMID:
19564297
6.

The effect of zanamivir treatment on influenza complications: a retrospective cohort study.

Cole JA, Loughlin JE, Ajene AN, Rosenberg DM, Cook SE, Walker AM.

Clin Ther. 2002 Nov;24(11):1824-39.

PMID:
12501877
7.

Effect of oseltamivir on the risk of pneumonia and use of health care services in children with clinically diagnosed influenza.

Barr CE, Schulman K, Iacuzio D, Bradley JS.

Curr Med Res Opin. 2007 Mar;23(3):523-31.

PMID:
17355734
8.

Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir.

Nordstrom BL, Sung I, Suter P, Szneke P.

Curr Med Res Opin. 2005 May;21(5):761-8.

PMID:
15969875
10.

Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study.

Nordstrom BL, Oh K, Sacks ST, L'Italien GJ.

Antivir Ther. 2004 Apr;9(2):187-95.

PMID:
15134180
11.

Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F.

Arch Intern Med. 2003 Jul 28;163(14):1667-72.

PMID:
12885681
12.

Antiviral drugs in influenza: an adjunct to vaccination in some situations.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):21-30.

PMID:
16548114
13.

Factors associated with early hospital discharge of adult influenza patients.

Lee N, Chan PK, Choi KW, Lui G, Wong B, Cockram CS, Hui DS, Lai R, Tang JW, Sung JJ.

Antivir Ther. 2007;12(4):501-8.

PMID:
17668558
14.

The influence of oseltamivir treatment on the risk of stroke after influenza infection.

Madjid M, Curkendall S, Blumentals WA.

Cardiology. 2009;113(2):98-107. doi: 10.1159/000172796. Epub 2008 Nov 15.

15.

The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease.

Nichol KL, Baken L, Wuorenma J, Nelson A.

Arch Intern Med. 1999 Nov 8;159(20):2437-42.

PMID:
10665892
16.

Risk for respiratory events in a cohort of patients receiving inhaled zanamivir: a retrospective study.

Loughlin JE, Alfredson TD, Ajene AN, Cole JA, Cook SE, Rosenberg DM, Walker AM.

Clin Ther. 2002 Nov;24(11):1786-99.

PMID:
12501874
17.

Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.

Smith JR, Sacks S.

Int J Clin Pract. 2009 Apr;63(4):596-605. doi: 10.1111/j.1742-1241.2009.02010.x.

PMID:
19335705
18.
19.

Outcome of influenza infection managed with oseltamivir in lung transplant recipients.

Ison MG, Sharma A, Shepard JA, Wain JC, Ginns LC.

J Heart Lung Transplant. 2008 Mar;27(3):282-8. doi: 10.1016/j.healun.2007.11.575.

PMID:
18342750
20.

Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.

Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ.

J Manag Care Pharm. 2010 May;16(4):264-75.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk